IL10 and autoimmune disease: Expression of TLR1, TLR2, TLR4, TLR7 and TLR9 transcripts has been reported on B cells (Barr et al., 2007), and TLR-activated B cells are capable of resolving autoimmune disorders by inhibiting pathogenic T cells via IL10 production (Lampropoulou et al., 2008).